Mouse Angiopoietin 2 ANG2 ELISA Kit (BG-MUS10137)
search
  • Mouse Angiopoietin 2 ANG2 ELISA Kit (BG-MUS10137)

Mouse Angiopoietin 2 ANG2 ELISA Kit

Catalog # BG-MUS10137

Print

$675.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

156 - 10,000 pg/mL

Sensitivity

10.0 pg/mL

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample volume

100 µL final volume, dilution factor varies on samples.

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant Mouse Angiopoietin-2 standard: 2 vials.

 2. One 96-well plate precoated with anti- Mouse Angiopoietin-2 Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 130 µL, dilution 1:100.

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

9. Stop solution: 10 mL x1.

10. Washing solution (20x): 25 mL x1.

 

 

Background

 

Angiopoietin-2 (Ang-2) is a member of the vascular growth factor family that also includes Ang-1 and Ang-4 in humans. Ang-2 is characterized by an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain. Ang-2 is approximately 60% identical to its homolog Ang-1. Mature mouse Angiopoietin-2 shares 86% and 96% amino acid (aa) sequence identity with human and rat Angiopoietin-2, respectively. Expression of human Ang-2 is restricted postnatally to pro-angiogenic regions including the placenta, ovaries, and uterus, while mouse Ang-2 is widely expressed in the mouse embryo.

Both Ang-1 and Ang-2 are ligands for the endothelial cell receptor tyrosine kinase Tie-2. The regulation of Ang-2/Tie-2 signaling is complicated, leading to inhibition in certain cell types or conditions, and activation in others. It is reported that Ang-1, but not Ang-2, could stimulate Tie-2 tyrosine phosphorylation in human umbilical vein endothelial cells (HUVECs), suggesting that Ang-2 could act as a competitive inhibitor of Ang-1 signaling. Overexpression of Ang-2 leads to disruption of embryonic blood vessel formation, a phenotype similar to that of Tie-2 knockouts, supporting further that Ang-2 acts as an Ang-1/Tie-2 inhibitor. In contrast, altering incubation times or elevating Ang-2 concentrations can result in Tie-2 activation in HUVECs. Ang-2 promotes endothelial cell death and vessel regression by itself, but can promote new vessel formation together with VEGF. Ang-2-mediated destabilization of mature vessel structures in the presence of VEGF may play a role in the angiogenesis of tumor tissues. It is shown that Ang-2 is elevated in colon carcinoma, gastric carcinoma, glioblastoma, glioma, hepatocellular carcinoma, neuroblastoma and non-small cell lung cancer.

 

New